Statements (56)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
biotechnology company
|
| gptkbp:acquisition |
Lineage Cell Therapeutics
|
| gptkbp:advertising |
partnerships with research institutions
|
| gptkbp:businessModel |
biopharmaceutical development
|
| gptkbp:CEO |
C._Randal_Mills
|
| gptkbp:clinicalTrials |
gptkb:California
Phase 1 various locations Phase 2 multiple phases multiple sclerosis safety and efficacy positive outcomes spinal cord injury published in scientific journals published data evaluate safety and efficacy adaptive trial design Phase 1/2 study |
| gptkbp:collaborations |
gptkb:Cleveland_Clinic
academic institutions biotech companies |
| gptkbp:enrollment |
patients with spinal cord injury
|
| gptkbp:financials |
focused on regenerative medicine.
|
| gptkbp:focus |
cell therapy
|
| gptkbp:founded |
2013
|
| gptkbp:funding |
grants
|
| gptkbp:headquarters |
gptkb:California
|
| https://www.w3.org/2000/01/rdf-schema#label |
Asterias Biotherapeutics
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:investmentFocus |
private equity firms
Venture capital firms shareholder communications |
| gptkbp:is_a |
public company
|
| gptkbp:keyPeople |
Michael_L._West
|
| gptkbp:market |
gptkb:United_States
|
| gptkbp:notableEvent |
AST-OPC1
|
| gptkbp:partnerships |
gptkb:University_of_California,_Irvine
Asterias_Biotherapeutics_and_Lineage_Cell_Therapeutics |
| gptkbp:platforms |
cell-based therapies
|
| gptkbp:productLine |
cell therapies
|
| gptkbp:products |
AST-OPC1 and AST-VAC1
AST-VAC1 |
| gptkbp:publications |
peer-reviewed articles
|
| gptkbp:regulatoryCompliance |
gptkb:FDA
|
| gptkbp:research |
stem cell biology
advancing cell therapies |
| gptkbp:research_areas |
neurology
regenerative medicine cell replacement therapy |
| gptkbp:research_focus |
treatment of neurological disorders
|
| gptkbp:sells |
gptkb:NYSE_American
|
| gptkbp:subsidiary |
Lineage Cell Therapeutics
|
| gptkbp:supportRole |
experts in regenerative medicine
|
| gptkbp:technology |
pluripotent stem cells
|
| gptkbp:website |
www.asteriasbiotherapeutics.com
|